Pancreatic neuroendocrine tumors harbor recurrent somatic genetic alterations affecting genes in the PI3K/AKT/mTOR, p53, and DNA damage repair pathways. This evidence concerns the gene AKT1 and pancreatic neuroendocrine tumor.